USFDA APPLICATION NUMBER - 50705 / DOSAGE - TABLET;ORAL - 50MG;300MG;120MG
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
isoniazid(UNII: V83O1VOZ8L) (isoniazid - UNII:V83O1VOZ8L) | isoniazid | 50mg |
pyrazinamide(UNII: 2KNI5N06TI) (pyrazinamide - UNII:2KNI5N06TI) | pyrazinamide | 300mg |
rifampin(UNII: VJT6J7R4TR) (rifampin - UNII:VJT6J7R4TR) | rifampin | 120mg |
Inactive Ingredients
Ingredient Name | sanofi-aventis U.S. LLC |
---|---|
acacia(5C5403N26O) | |
aluminum hydroxide(5QB0T2IUN0) | |
calcium stearate(776XM7047L) | |
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311) | |
carnauba wax(R12CBM0EIZ) | |
ferric oxide red(1K09F3G675) | |
ferrosoferric oxide(XM0M87F357) | |
kaolin(24H4NWX5CO) | |
lecithin, soybean(1DI56QDM62) | |
magnesium carbonate(0E53J927NA) | |
PARAFFIN(I9O0E3H2ZE) | |
POVIDONE, UNSPECIFIED(FZ989GH94E) | |
propylene glycol(6DC9Q167V3) | |
rosin(88S87KL877) | |
shellac(46N107B71O) | |
silicon dioxide(ETJ7Z6XBU4) | |
sodium lauryl sulfate(368GB5141J) | |
sucrose(C151H8M554) | |
talc(7SEV7J4R1U) | |
titanium dioxide(15FIX9V2JP) | |
white wax(7G1J5DA97F) |
LOOKING FOR A SUPPLIER?